Emergent BioSolutions Balance Sheet (2010-2026) | EBS

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	447.50M	403.80M	576.10M	435.80M	358.10M	240.90M	642.60M	430.20M	88.60M	87.80M	111.70M	78.50M	69.70M	149.90M	99.50M	149.10M	267.30M	245.50M	205.40M	160.30M
Short-term Investments (Quarter)	0.20M	0.20M	0.20M	0.20M	0.20M	0.10M						0.50M	1.30M	6.50M	6.10M	3.70M	3.70M	3.70M	3.70M	1.20M
Cash & Current Investments (Quarter)	447.70M	404.00M	576.30M	436.00M	358.30M	241.00M	642.60M	430.20M	88.60M	87.80M	111.70M	79.00M	71.00M	156.40M	105.60M	152.80M	271.00M	249.20M	209.10M	161.50M
Receivables - Net (Quarter)	261.90M	197.00M	278.90M	181.80M	175.00M	189.20M	159.20M	155.90M	290.10M	216.50M	191.00M	233.50M	196.30M	121.30M	135.40M	174.00M	79.80M	149.50M	84.20M	104.10M
Receivables - Other (Quarter)	51.60M	57.60M	51.60M	66.60M	55.10M	72.30M	57.20M	49.80M	51.80M	61.00M	51.40M	41.60M	82.50M	19.20M	19.60M	30.90M	22.90M	19.30M	18.20M	18.30M
Receivables (Quarter)	313.50M	254.60M	330.50M	248.40M	230.10M	261.50M	216.40M	205.70M	341.90M	277.50M	242.40M	275.10M	278.80M	140.50M	155.00M	204.90M	102.70M	168.80M	102.40M	122.40M
Raw Materials (Quarter)
Work In Process (Quarter)
Finished Goods (Quarter)
Inventory (Quarter)	386.40M	364.60M	344.50M	400.70M	425.50M	528.20M	350.70M	367.90M	354.30M	354.10M	328.90M	333.40M	317.50M	322.70M	311.70M	314.00M	338.60M	356.30M	343.40M	327.60M
Current Deferred Tax Assets (Quarter)
Prepaid Assets (Quarter)	66.10M	88.30M	70.20M	81.80M	125.40M	139.90M	57.90M	41.70M	44.70M	62.40M	47.90M	36.50M	36.00M	61.00M	26.90M	30.20M	24.00M	25.60M	25.80M	26.90M
Current Assets (Quarter)	1,162.10M	1,111.50M	1,269.90M	1,100.30M	1,084.20M	1,098.30M	1,210.40M	1,221.30M	777.70M	720.80M	679.50M	682.40M	654.50M	661.40M	598.70M	706.80M	719.50M	786.90M	662.50M	637.60M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	743.50M	768.70M	800.10M	807.50M	798.40M	806.80M	817.60M	716.80M	395.50M	395.40M	382.80M	379.40M	306.20M	278.10M	270.60M	221.00M	216.10M	209.80M	205.40M	199.40M
Goodwill (Quarter)	266.60M	266.50M	224.90M	224.90M	224.90M	224.90M	218.20M	218.20M	218.20M
Intangibles (Quarter)	633.10M	618.60M	604.60M	590.60M	576.60M	724.90M	728.80M	608.90M	592.80M	582.80M	566.60M	550.40M	534.10M	517.80M	501.50M	485.20M	469.00M	452.70M	436.50M	470.40M
Goodwill & Intangibles (Quarter)	899.70M	885.10M	829.50M	815.50M	801.50M	949.80M	947.00M	827.10M	811.00M	582.80M	566.60M	550.40M	534.10M	517.80M	501.50M	485.20M	469.00M	452.70M	436.50M	470.40M
Long-Term Deferred Tax (Quarter)
Other Non-Current Assets (Quarter)	109.90M	102.20M	58.20M	57.10M	51.30M	40.80M						0.50M	1.30M	6.50M	18.90M	3.70M	3.70M	3.70M	14.20M	13.00M
Non-Current Assets (Quarter)	1,753.10M	1,756.00M	1,687.80M	1,680.10M	1,651.20M	1,797.40M	1,955.90M	1,728.50M	1,401.10M	1,172.30M	1,143.70M	1,121.20M	859.00M	816.40M	791.00M	719.30M	697.60M	674.10M	656.10M	682.80M
Assets (Quarter)	2,915.20M	2,867.50M	2,957.70M	2,780.40M	2,735.40M	2,895.70M	3,166.30M	2,949.80M	2,178.80M	1,893.10M	1,823.20M	1,803.60M	1,513.50M	1,477.80M	1,389.70M	1,426.10M	1,417.10M	1,461.00M	1,318.60M	1,320.40M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	151.80M	135.20M	128.90M	107.30M	106.20M	101.00M	103.50M	124.20M	108.30M	112.70M	112.20M	100.20M	95.90M	82.10M	60.90M	58.10M	63.70M	57.40M	55.60M	39.50M
Notes Payables (Quarter)	28.80M	31.60M	31.60M	31.60M	31.60M	21.20M	957.30M	950.70M	455.20M	413.60M	413.70M	459.20M	415.20M	0.80M
Payables (Quarter)	180.60M	166.80M	160.50M	138.90M	137.80M	122.20M	1,060.80M	1,074.90M	563.50M	526.30M	525.90M	559.40M	511.10M	82.90M	60.90M	58.10M	63.70M	57.40M	55.60M	39.50M
Accumulated Expenses (Quarter)	63.20M	42.90M	88.70M	56.40M	40.30M	35.70M	87.30M	56.80M	31.20M	17.00M	74.10M	14.30M	17.20M	16.10M	56.10M	13.20M	31.50M	13.90M	12.20M	9.40M
Other Accumulated Expenses (Quarter)	100.20M	82.30M	73.10M	24.60M	24.20M	24.00M	45.90M	25.20M	28.90M	38.20M	32.70M	14.50M	14.60M	67.60M	21.90M	11.10M	13.60M	24.10M	10.80M	8.00M
Short term Debt (Quarter)
Current Taxes (Quarter)															5.80M				6.80M	7.20M
Current Deferred Revenue (Quarter)	103.40M	82.10M	16.40M	15.90M															5.00M	17.60M
Curent Deferred Tax Liability (Quarter)
Total Current Liabilities (Quarter)	377.80M	365.40M	374.00M	249.20M	276.70M	264.40M	1,228.90M	1,215.70M	693.20M	664.00M	651.30M	630.20M	619.70M	229.90M	162.40M	111.90M	127.10M	136.50M	132.20M	148.70M
Non-Current Liabilities
Non-Current Debt (Quarter)	825.20M	817.30M	809.40M	801.50M	793.60M	1,032.10M	448.50M	447.70M	448.00M	448.20M	446.50M	446.70M	447.00M	661.80M	663.70M	665.70M	667.80M	663.10M	572.10M	573.60M
Non-Current Deffered Revenue (Quarter)	48.90M	45.30M	4.70M	5.90M
Minority Interest (Quarter)
Liabilities from Discontinued Operations (Quarter)								37.50M					10.10M			4.80M	4.70M	4.50M
Non-Current Deferred Tax Liability (Quarter)	53.20M	53.00M	130.70M	94.80M	93.40M	113.90M	125.40M	59.70M	57.90M	52.40M	58.90M	34.80M	34.80M	41.90M	48.90M	60.40M	46.50M	36.30M	37.80M	33.30M
Other Non-Current Liabilities (Quarter)	5.00M	37.70M	69.50M	4.40M	58.50M	52.30M	41.50M	24.10M	23.40M	31.30M	28.90M	28.00M	25.70M	35.80M	39.10M	35.40M	39.50M	42.60M	53.90M	41.70M
Total Non-Current Liabilities (Quarter)	1,366.50M	1,307.10M	1,276.70M	1,200.70M	1,163.70M	1,410.40M	1,737.10M	1,723.10M	1,199.10M	1,164.60M	1,145.00M	1,111.70M	1,101.50M	933.60M	867.80M	838.00M	841.40M	835.90M	742.10M	755.60M
Total Liabilities (Quarter)	1,371.50M	1,344.80M	1,346.20M	1,205.10M	1,222.20M	1,462.70M	1,778.60M	1,747.20M	1,222.50M	1,195.90M	1,173.90M	1,139.70M	1,127.20M	969.40M	906.90M	873.40M	880.90M	878.50M	796.00M	797.30M
Shareholder's Equity
Total Debt (Quarter)	825.20M	817.30M	809.40M	801.50M	793.60M	1,032.10M	448.50M	447.70M	448.00M	448.20M	446.50M	446.70M	447.00M	661.80M	663.70M	665.70M	667.80M	663.10M	572.10M	573.60M
Common Equity (Quarter)	1,543.70M	1,522.70M	1,611.50M	1,566.90M	1,508.30M	1,433.00M	1,387.70M	1,204.10M	957.70M	697.20M	649.30M	663.90M	386.30M	508.40M	482.80M	552.70M	536.20M	582.50M	522.60M	523.10M
Shareholder's Equity (Quarter)	1,543.70M	1,522.70M	1,611.50M	1,566.90M	1,508.30M	1,433.00M	1,387.70M	1,204.10M	957.70M	697.20M	649.30M	663.90M	386.30M	508.40M	482.80M	552.70M	536.20M	582.50M	522.60M	523.10M
Liabilities and Shareholders Equity (Quarter)	2,915.20M	2,867.50M	2,957.70M	2,780.40M	2,735.40M	2,895.70M	3,166.30M	2,949.80M	2,178.80M	1,893.10M	1,823.20M	1,803.60M	1,513.50M	1,477.80M	1,389.70M	1,426.10M	1,417.10M	1,461.00M	1,318.60M	1,320.40M
Treasury Shares (Quarter)	1.20M	1.20M	3.80M	4.90M	5.60M	5.60M	5.60M	5.60M	5.60M	5.60M	5.60M	5.60M	5.60M	5.60M	5.60M	5.60M	6.70M	7.90M	8.70M	0.90M
Retained Earnings (Quarter)	801.20M	768.50M	-16.10M	-9.30M	-6.10M	-5.20M	738.70M	1.00M	289.70M	-2.60M	-5.70M	-12.80M	-5.50M	-7.30M	-212.40M	-6.10M	-156.40M	-7.50M	-7.50M	-153.00M

Research Tools

Emergent BioSolutions Balance Sheet (2010-2026) | EBS

Create an account

Sign In

Reset Password